Secondary solid malignancies after high-grade glioma treatment in pediatric patients
Due to the poor survival in high-grade glioma (HGG), secondary solid malignancies (SSM) following pediatric HGG are scarce. The authors present the experience from the HIT-HGG database in Germany, Austria, and Switzerland. Five out of 1228 pediatric HGG patients developed a SSM following a latency o...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
03 Aug 2015
|
| In: |
Pediatric hematology and oncology
Year: 2015, Volume: 32, Issue: 7, Pages: 467-473 |
| ISSN: | 1521-0669 |
| DOI: | 10.3109/08880018.2015.1050615 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.3109/08880018.2015.1050615 Verlag, Volltext: https://doi.org/10.3109/08880018.2015.1050615 
|
| Author Notes: | Michael Karremann, Marion Hoffmann, Martin Benesch, Robert Kwiecien, André O. von Bueren, and Christof M. Kramm |
| Summary: | Due to the poor survival in high-grade glioma (HGG), secondary solid malignancies (SSM) following pediatric HGG are scarce. The authors present the experience from the HIT-HGG database in Germany, Austria, and Switzerland. Five out of 1228 pediatric HGG patients developed a SSM following a latency of 29-122 months from primary HGG diagnosis. In 4 patients, the SSM may be attributed to previous radiotherapy or a tumor predisposition syndrome, reflected by a markedly increased cumulative incidence rate of SSM in patients with tumor predisposition. Survival was devastating, since none of the patients survived beyond 18 months from SSM diagnosis. |
|---|---|
| Item Description: | Gesehen am 01.02.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1521-0669 |
| DOI: | 10.3109/08880018.2015.1050615 |